product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Myosin IIc (D4A7) Rabbit mAb
catalog :
8189
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D4A7
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; human; 1:300; fig 4
Montalbano M, Curcurù G, Shirafkan A, Vento R, Rastellini C, Cicalese L. Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion. PLoS ONE. 2016;11:e0153613 pubmed publisher
Deng J, Yuan S, Pennati A, Murphy J, Wu J, Lawson D, et al. Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response. Cancer Res. 2014;74:4133-44 pubmed publisher
Woodling N, Wang Q, Priyam P, Larkin P, Shi J, Johansson J, et al. Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling. J Neurosci. 2014;34:5882-94 pubmed publisher
product information
SKU :
8189S
Product-Name :
Myosin IIc (D4A7) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Cytoskeletal Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
230
Host :
Rabbit
Target :
Myosin IIc
Primary-Protein :
MYH14
Alt-Names :
DFNA4,DKFZp667A1311,FLJ13881,FLJ43092,FP17425,KIAA2034,MHC16,MYH14,MYH14 variant protein,MYH17,Myosin heavy chain 14,Myosin heavy chain, non-muscle IIc,Myosin-14,NMHC II-C,NMHC-II-C,Non-muscle myosin heavy chain IIc,myosin,myosin, heavy chain 14, non-muscle,myosin, heavy polypeptide 14,nonmuscle myosin heavy chain II-C
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.